scispace - formally typeset
C

Charles P. Olinger

Researcher at University of Cincinnati

Publications -  18
Citations -  5868

Charles P. Olinger is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Cerebral infarction & Stroke. The author has an hindex of 14, co-authored 18 publications receiving 5335 citations. Previous affiliations of Charles P. Olinger include University of Iowa.

Papers
More filters
Journal ArticleDOI

Measurements of acute cerebral infarction: a clinical examination scale.

TL;DR: A 15-item neurologic examination stroke scale for use in acute stroke therapy trials was designed and interrater reliability for the scale was found to be high, and test-retest reliability was also high, suggesting acceptable examination and scale validity.
Journal ArticleDOI

Measurements of acute cerebral infarction: lesion size by computed tomography.

TL;DR: As part of a prospective therapy study of 65 patients with acute, nonhemorrhagic, cerebral infarction, computed tomographic scans of the head were obtained at admission, 7-10 days, and 3 months for the presence, site, size, and volume measurement of the infarctions.
Patent

Focusing fiber-optic needle endoscope

TL;DR: A needle endoscope as mentioned in this paper includes a hollow needle of about 18-gauge, a lens system within the needle, an image transmitting bundle of flexible fiber-optic rods within the needles, a plurality of illumination transmitters within the rods, and apparatus to shift the image transmission bundle with respect to the lens system and needle to provide focus adjustment for focusing the endoscope on objects at various distances from the end of the needle.
Journal ArticleDOI

Hyperdense middle cerebral artery: incidence and quantitative significance.

TL;DR: The hyperdensemiddle cerebral artery sign (HMCAS) is recognized as a CT finding that indicates thrombus or embolus within the middle cerebral artery.
Journal ArticleDOI

High-dose intravenous naloxone for the treatment of acute ischemic stroke.

TL;DR: The experience suggests that naloxone is safe at the dose used, but data for efficacy are inconclusive, and there was no correlation between such a loading dose response and clinical outcome at 3 months.